HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
for Juvenile Myelomonocytic Leukemia
1 location in Seattle
Sponsor: Fred Hutchinson Cancer Center
Sex: All·Age: Up to 80
Code: NCT03326921·Phase 1·Recruiting